In a recent transaction, Jason Phillips, President of Celestica Inc . (NYSE:CLS), sold 95,979 common shares of the company. The stock has been a stellar performer, surging 289% over the past year to ...

Net Interest Income increased $3.4 million, or 3.8%, to $91.8 million for the year ended December 31, 2024, from $88.4 million for the year ended ...

BD announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD’s Biosciences and Diagnostic ...

Ohio-based Sequoia Financial Group and Carlson Capital Management recently announced that “they have reached an agreement” ...

Voya Investment Management achieved 20% earnings growth and over 4% organic growth. Katz highlighted that Voya returned $800 million in excess capital to shareholders in 2024 and anticipates ...

In recent transactions involving abrdn Life Sciences Investors (NYSE:HQL), significant sales of common stock were reported by ...

Hexaware Technologies IPO comprises of entirely offer-for-sale (OFS) of Rs 8,750 crore worth shares by promoter CA Magnum ...

Capital One's credit card business requires high provisions for credit losses, but its strong net interest margin comfortably ...

Australia's Macquarie is set to shutter its U.S. debt capital markets arm, as it plans to focus its resources on private ...

In accordance with the proposed Finance Bill 2025, the rebate under Section 87A is now applicable up to a total income of Rs ...

From a purely business financials perspective, a large part of the reason for the sell-off stemmed from slowing growth in ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.